Real‐Life Comparison of Antivirals for SARS‐CoV‐2 Omicron Infection in Patients With Hematologic Mal...
Real‐Life Comparison of Antivirals for SARS‐CoV‐2 Omicron Infection in Patients With Hematologic Malignancies
About this item
Full title
Author / Creator
Aiello, Tommaso Francesco , Peyrony, Olivier , Chumbita, Mariana , Monzó, Patricia , Lopera, Carlos , Puerta‐Alcalde, Pedro , Magnano, Laura , Fernández‐Avilés, Francesc , Cuesta, Genoveva , Tuset, Montse , Mensa, Josep , Esteve, Jordi , Marcos, Maria Angeles , Soriano, Alex and Garcia‐Vidal, Carolina
Publisher
England: John Wiley & Sons, Inc
Journal title
Language
English
Formats
Publication information
Publisher
England: John Wiley & Sons, Inc
Subjects
More information
Scope and Contents
Contents
ABSTRACT
Background
We aimed to describe a cohort of hematologic patients with COVID‐19 treated with antivirals early.
Methods
Non‐interventional chart review study. Comparison of baseline characteristics and outcomes in high‐risk hematologic patients treated with remdesivir between December 2021 and April 2022 versus those treated with...
Alternative Titles
Full title
Real‐Life Comparison of Antivirals for SARS‐CoV‐2 Omicron Infection in Patients With Hematologic Malignancies
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10928260
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10928260
Other Identifiers
ISSN
1750-2640,1750-2659
E-ISSN
1750-2659
DOI
10.1111/irv.13264
